GEO_Series,curators,select,batches,batches.if.not.tests.1,balanced_groups,Critical,library_purification,Instrument,LibraryLayout,SamplesPairing,Cell type,Control,Treat,Control_desc,Treat_desc,mesh_terms (pipe-separated list),Notes,samples_homogeneity,Samples Confounding information,Samples properties,Batched Samples properties,Samples extension,journal,pmid,2-YEAR-IF2020,5-YEAR-IF2020,select.bak,batches.bak,BioProject,SRA Study,DEG_notes,Cor_notes,curators.bak,Samples homogeneity
GSE100925,JF,1.0,0.0,1.0,1.0,"batch correction mentioned in paper and GEO but not annotated in metadata (GEO, SRA, paper), yet considering prefix in sample name as batch ID (GEO Series file)",,Illumina HiSeq 2000,SINGLE,0.0,human breast,Normal,Breast_tumor,Adjacent normal,Breast tumor,Breast Neoplasms,Data not analyzed directly in publication. Paper focused on another RNA-seq dataset (GSE117970; also in qcGenes). Clinical parameters annotated only for a subset of the samples,False,,"12 breast tumor and 12 adjacent normal breast in 1 supposed batch (supposed batch from sample names in GEO Series file); various clinical parameters (e.g. age, grades and histology) (including samples with no clinical details)",,,Cancer Cell,30930117.0,31.743,35.455,1.0,0.0,PRJNA393443,SRP111343,,,JF,
GSE104423,JF,0.0,0.0,0.0,,"2 batches mentioned for correction but not annotated (SRA, paper, GEO??)",,Illumina HiSeq 2500,SINGLE,0.0,peripheral blood mononuclear cell,Improving,Not_improving,Group I in paper,Group II in paper,Heart Failure,Batch not annotated; males; full clinical images in table 1 as image,False,,only males; improving vs not improving; 2 batches mentioned for correction but not annotated,,,PLoS ONE,29236770.0,3.24,3.272,0.0,0.0,PRJNA412585,SRP119122,,,JF,
GSE105130,JF,1.0,0.0,0.0,1.0,"no detailed demographics data, but paired samples",RNeasy Mini Kit,Illumina HiSeq 2000,PAIRED,1.0,liver,Adjacent-non-tumour,tumor,Adjacent normal,"Liver tissues\, Cancer","Carcinoma, Hepatocellular",technically paired samples but pair identifiers provided only in GEO Series file. Clear pairing information.,True,NI,"No detailed metadata (summary in Fig 1: 21 males and 4 females, age mostly >50, various grades ); all paired samples selected, except 2 samples that were duplicates of non-tumor samples",,,J Transl Med,31429776.0,5.531,5.76,1.0,0.0,PRJNA414787,SRP120360,,,JF,
GSE106899,JF,0.0,0.0,0.0,1.0,"no detailed demographics data, but paired samples",,Illumina HiSeq 2000,SINGLE,1.0,Lung tissue,Lung_tumor_adjacent,Lung_tumor,Tissue adjacent to lung tumor,Lung tumor tissue,Lung Neoplasms,Fraction: Total RNA; No detailed demographics data but summary in table 2. Sample pair Ids derived from source_name column of SRA metadata,True,,total RNA samples (not polyribosomal RNA samples); all paired lung tumor and adjacent tissue samples; 3/11 males; 62-75 years old,,,Eur Respir J,29794131.0,16.671,,1.0,0.0,PRJNA418402,SRP125001,,,JF,
GSE108643,JF,1.0,0.0,0.0,1.0,,,Illumina HiSeq 2500,SINGLE,0.0,Vastus Lateralis Muscle,Control,Control_Sport,lean men,lean men after sport,Obesity,paper behind paywall. No detailed demographics except gender in SRA and GEO Series file. Paper's abstract describe only young men. Full paper to check (paywall),True,,"male; 14 lean control men vs 14 same after sport boot (BMI<25, 18.5- 24.1 kg/m2, n=15)",,"There are 2 other groups: obese control and obese after sport, Ov/Ob (BMI?25, 25.5- 36.9 kg/m2, n=15); 19-30 years",Diabetes Obes Metab,34472674.0,6.577,,1.0,0.0,PRJNA427961,SRP127751,,,JF,
GSE114564,JF,1.0,0.0,0.0,1.0,"No detailed demographics in SRA, GEO Series file and papers","Truseq Stranded Total RNA Sample Preparation Kit (Illumina, San Diego, CA, USA)",Illumina HiSeq 2000,PAIRED,0.0,liver,Normal,Advanced_HCC,Healthy,"Liver tissues\, Cancer","Carcinoma, Hepatocellular",,False,NI,No detailed metadata; all 15 normal vs 15 randomly selected advanced HCC,,"To be balanced, fewer disease samples were selected than available. No extension but cirrhosis samples may be integrated with control.",,,,,1.0,0.0,PRJNA471801,SRP148066,,,JF,
GSE115397,JF,0.0,0.0,0.0,,not enough samples in possible control groups (n=3 or 4) that cluster separately in a PCA in the paper,,NextSeq 500,SINGLE,0.0,,Macrophages,TAM,Macrophages from adjacent non tumor tissue,TAMs from Gliomas,Glioma|Macrophages|Tumor Associated Macrophages,,,,,,,,,,,0.0,0.0,PRJNA474825,SRP149884,,,JF,
GSE115643,JF,0.0,0.0,0.0,,irrelevant MeSH term (not a disease) and very uncommon distribution of gene-quality correlation coefficients,,NextSeq 500,SINGLE,0.0,,Control,EVl1,(Empty Vector | Untransfected ) + Untreated,(EVl1-WT | Evl-1-AQA) + Untreated,Neoplasms,"Batch 1 (day3 and 17, WT); Cell line!; irrelavant MeSH term; Weird distribution of genesâ€™ FDR vs quality",,,,,,Nucleic Acids Res,29939287.0,16.971,15.542,0.0,0.0,PRJNA475639,SRP150287,,,JF,
GSE116250,JF,1.0,0.0,0.0,1.0,,,Illumina HiSeq 2500,SINGLE,0.0,left ventricle,Control,ICM,non-failing,ischemic cardiomyopathy,Heart Failure|Myocardial Infarction,"Control and ICM are group of comparable size (10 and 11 samples). Yet, 30 samples labelled as ""dilated cardiomyopathy"" could be grouped with ICM (no figure in publication to support this).",True,,all 11 male non failing vs 10 ischemic cardiomyopathy. Disease group a bit older (mean age 56 vs 48),,may add 3 females per group,Nat Commun,32868781.0,14.919,14.123,1.0,0.0,PRJNA477855,SRP151309,,,JF,
GSE116946,JF,0.0,0.0,0.0,,batch reported but not documented; technically paired samples but no pair identifiers provided (only telling if part of a paired analysis or not); tables in supplementary provide gender and age for some samples but are impossible to map to data (no common identifier),,Illumina HiSeq 2500,SINGLE,0.0,macrophages,Macrophages,TAM,Macrophages from adjacent non tumor tissue,TAMs from lung cancer,"Lung Neoplasms|Carcinoma, Non-Small-Cell Lung|Macrophages|Tumor Associated Macrophages",,False,NI,No detailed metadata (impossible to map info from suppl files about some samples to data),,,J Immunother Cancer,32699181.0,13.751,13.864,0.0,0.0,PRJNA480670,SRP153069,,,JF,
GSE117875,JF,1.0,0.0,0.0,1.0,"no demogr info in SRA, GEO Series file, but in Table 1 (unclear sample id mapping): disease group slightly younger (mean 14 vs 16), all white but 1 black, 50% males in each group",Directional polyA RNA-seq,Illumina HiSeq 2500,SINGLE,0.0,intestinal epithelial cells,Control,Crohn,healthy control,newly-diagnosed Crohn''s disease,Crohn Disease,,True,,12-18 years-old patients. 7 controls and 6 diseases.,,,JCI Insight,30232290.0,8.315,,1.0,0.0,PRJNA483489,SRP155771,,,JF,
GSE119834,JF,1.0,0.0,0.0,1.0,"stem cells as control. No demographics data in GEO Series file, SRA or paper (no mention at all!!). 44 controls vs 44 diseases",,Illumina HiSeq 2500,PAIRED,0.0,glioblastoma multiforme; glioblastoma stem cells,Control,GBM,glioblastoma stem cell,glioblastoma multiforme,Glioma|Glioblastoma,,False,NI,No detailed available. 44 controls. 44 disease,,1 disease sample could be added (not included to balance groups),J Exp Med,30948495.0,14.307,11.5,1.0,0.0,PRJNA490436,SRP161553,,,JF,
GSE120099,JF,0.0,0.0,0.0,,iPSC of very few individuals sampled multiple times,,Illumina HiSeq 2500,PAIRED,0.0,iPSC,Non_Risk,Risk_CVD,individuals homozygous non-risk (NN-green) for 9p21.3 CAD-risk region,individuals homozygous risk (RR-red) for 9p21.3 CAD-risk region,Cardiovascular Diseases,"RR_WT/KO vs NN_WT/KO of day 0 and day 3 from batch 1; Genotype manually reannotated (article suppl. Info 2), from all batches for the batched analysis",True,,RR WT and RR KO samples (no NN WT and NN KO samples); day 0 and day 3 in batch 1; cell lines and replicates from few individuals,cell lines and replicates from few individuals; day 0 and day 3,KO and WT not differentiated in day 0 and day 3,Cell,30528432.0,41.582,46.898,1.0,1.0,PRJNA491651,SRP161997,,,JF,
GSE120852,JF,0.0,0.0,0.0,,Severe gender imbalance between groups. Table S1: group NF 20% male and group BiV-HF 100%,polyA RNA,Illumina HiSeq 2500,SINGLE,0.0,right and left ventricle,Control,Heart_Failure,Not Failing,BiVentricular Heart Failure,Heart Failure|Myocardial Infarction,,False,,Non failing vs BiVentricular Heart Failure; not homogeneous sample groups,,"Left and right ventricule tissue; Varying average proportions of male/female per group (control 20%, disease 60-100%); Varying age per group (younger in control group)",JCI Insight,30232290.0,8.315,,1.0,0.0,PRJNA494710,SRP163478,,,JF,
GSE121519,JF,0.0,0.0,0.0,,exoRNA-seq; 4 samples per group,,ILLUMINA,PAIRED,0.0,exosomes from cerebrospinal fluid (CSF),Control,sALS,Control,sALS,Amyotrophic Lateral Sclerosis,,True,,all male; similar age group (51-67),,,BMC Med Genomics,30630471.0,3.063,3.476,1.0,0.0,PRJNA497536,SRP166162,,,JF,
GSE122619,JF,0.0,0.0,0.0,,Not Illumina,,Ion Torrent Proton,SINGLE,0.0,Peripheral Blood Mononuclear Cells,Uninfected,MSmeg,Uninfected,Infected with M Smeg,Tuberculosis|Bacterial Infections,12 hours post infection,True,,12 hours post infection + control,,,Virulence,32052695.0,5.882,6.489,1.0,0.0,PRJNA505785,SRP169071,,,JF,
GSE123496,JF,1.0,0.0,0.0,1.0,few samples: 5 vs 5,,Illumina HiSeq 3000,SINGLE,0.0,corpus callosum,Control,MS,healthy control,MS,Multiple Sclerosis,corpus callosum,True,,"all 5 fresh frozen corpus callosum in MS patients and 5 age- and sex-matched healthy controls. Paper: ""five female patients with MS (mean age, 57.6 y) and five female age-matched healthy controls (mean age, 56.2 y)""",,,Proc Natl Acad Sci,31040210.0,11.205,12.291,1.0,0.0,PRJNA508944,SRP173190,,,JF,
GSE125583,JF,1.0,0.0,0.0,1.0,RNA integrity (RIN) scores at least 5 . Clinical info in Supplementary Material 2 (XLS).,polyA,Illumina HiSeq 2500,SINGLE,0.0,RNA from fusiform gyrus,Control,Alzheimer,control,Alzheimer's disease,Alzheimer Disease,,True,,70-90-year males; n=30 per group (control and disease),,No extension but many samples available (158 men and 130 females). Only 7/37 more men controls possible to include (female controls are less: 33). Balancing men and women per group may be used to increase the number of samples if required,Cell Rep,32610143.0,9.423,10.394,1.0,0.0,PRJNA516886,SRP181886,,,JF,
GSE126848,JF,0.0,0.0,0.0,,batch reported but not documented (PCA in article divide samples by supposed batch),,NextSeq 500,SINGLE,0.0,Liver,healthy,NASH,healthy,NASH,Non-alcoholic Fatty Liver Disease|Fatty Liver,"male; paper mentions "" Only samples of high-quality RNA (RNA integrity number ?7.5) were used in the mRNA sample preparation for sequencing."" and ""read counts were corrected for batch effects from sample collection sites in the cohorts containing NAFL/NASH patients by using the R package Limma""",True,,male; all NASH vs healthy samples; similar age (Table 1 in publication),,,Am J Physiol Gastrointest Liver Physiol,30653341.0,4.052,4.545,0.0,0.0,PRJNA523510,SRP186450,,,JF,
GSE142582,JF,0.0,0.0,0.0,,,,Illumina HiSeq 4000,SINGLE,1.0,skin,Adajcent,Psoriasis,healthy adjacent skin control,Psoriatic plaque tissue (PS),Psoriasis,paywall; paired samples but not not documented (Using age to identify pairs),False,,5 paired samples per groups; all ages; Samples with AvgSpotLen>200,,,J Dermatol Sci,32381429.0,4.563,,1.0,0.0,PRJNA597533,SRP238713,,,JF,
GSE147339,JF,1.0,0.0,0.0,1.0,"no demogr info in GEO or SRA, and no paper linked.",,Illumina HiSeq 4000,SINGLE,0.0,Whole blood,Control,Psoriasis,Control,Psoriasis,Psoriasis,Annotated as PAIRED but automatically downloaded as SINGLE,False,,all 10 control and all 10 disease samples. no details available except group,,,,,,,1.0,0.0,PRJNA613909,SRP253611,,,JF,
GSE148355,JF,1.0,0.0,0.0,1.0,South Korea.,Trizol reagent. Illumina TruSeq RNA Sample Prep Kit (Cat#FC-122-1001),Illumina HiSeq 2000,PAIRED,0.0,,Control,Liver_Cancer,"Normal, fibrosis and Cirrhosis liver tissue",Gastric cancer Liver tissues,"Carcinoma, Hepatocellular",Some samples are paired but no control samples.  demographics data in GEO Series file.,True,,"11 controls (excluding a female replicate and samples without gender annotations; 7 males, 4 females; mean age 57) + 11 approximately age- and gender-matched disease samples (7 males, 4 females; mean age 60)",,"4 more controls without age and gender annotation available, and many more disease samples.",NPJ Precis Oncol,33772139.0,8.254,9.538,1.0,0.0,PRJNA624047,SRP255859,,,JF,
GSE156044,JF,0.0,0.0,0.0,,"few samples (total=8); no demographics data for RNA-seq samples (GEO Series file, SRA and paper; even in Table S1 referenced by authors)",,Illumina NovaSeq 6000,SINGLE,0.0,mesenteric adipose tissue,Control,Crohn,Non_Crohn's disease,Crohn's disease,Crohn Disease,Only 8 samples,False,NI,no detailed information on samples,,,Cell,32991841.0,41.582,46.898,1.0,0.0,PRJNA656537,SRP277065,,,JF,
GSE159851,JF,1.0,0.0,0.0,1.0,few samples: 5 vs 5 samples,,Illumina HiSeq 4000,SINGLE,0.0,brain,Control,gbm,human brain control,glioblastoma multiforme,Glioma|Glioblastoma,"contains also 7 adenocarcinoma metastasis, deselected. Age info available in suppl table 3.",False,,"gbm: age=55-70, 1/5 female; randomly chosen controls with age=5-73, 1/5 females; unbalance origin of tissue between groups (right, left brain)",,,Neuro Oncol,33560373.0,12.4,12.997,1.0,0.0,PRJNA670696,SRP288330,,,JF,
GSE163044,JF,0.0,0.0,0.0,,cell lines,,Illumina HiSeq 2000,PAIRED,0.0,foetal CNS tissue,Control,gbm,Normal tissue mix from around the brain,glioblastoma multiforme,Glioma|Glioblastoma,Possibility to use either normal tissue or normal neural stem cells as control. Tissue for now.,False,NI,No detailed available. Gbm samples from various parts of the brain.,,,Cell Stem Cell,33631116.0,24.633,13.144,1.0,0.0,PRJNA684512,SRP297662,,,JF,
GSE25599,JF,1.0,0.0,0.0,1.0,,,Illumina Genome Analyzer,SINGLE,1.0,Liver,Control,Liver_Cancer,"Liver tissues\, Non-cancerous adjacent","Liver tissues\, Cancer","Carcinoma, Hepatocellular","no demographics info in SRA or GEO Series file, but in Table S1. Clear pairing information.",True,,males; paired samples; 2 samples per patient,,2 females and replicates of male samples,PLoS ONE,22043308.0,3.24,3.272,1.0,0.0,PRJNA134241,SRP004768,,,JF,
GSE46224,JF,0.0,0.0,0.0,,,,Illumina HiSeq 2000,PAIRED,0.0,human left ventricle apex tissue,Control,Heart_Failure,non-failing,ischemic and non-ischemic cardiomyopathy - pre-LVAD,Heart Failure|Myocardial Infarction,,True,,male only; non-failing vs heart failure pre LVAD (ICM+NICM),,,Circulation,24429688.0,29.69,9.723,1.0,0.0,PRJNA198165,,,,JF,
GSE54456,JF,1.0,0.0,0.0,1.0,"no gender and batch annotation, other demographic data are balanced (summary given in article)",polyA (suppl methods),Illumina Genome Analyzer,SINGLE,0.0,skin,normal_skin,Psoriasis_skin,healthy skin control,Psoriasis,Psoriasis,,False,NI,"28 randomly chosen controls and same number of disease samples (56/172 samples). No detailed available. Summary in article: ""The mean age of patients with psoriasis was 49ï¿½13.9 years and 39.03ï¿½12.63 years in controls. The mean BMI for psoriasis versus controls was 29.31ï¿½5.82 versus 27.16 ï¿½5.96"", ""All subjects were of European Caucasian""",,No extension but not all samples were selected,J Invest Dermatol,24441097.0,8.551,4.368,1.0,0.0,PRJNA236547,SRP035988,,,JF,
GSE55296,JF,0.0,0.0,0.0,,uncommon platform,,AB 5500xl Genetic Analyzer,PAIRED,0.0,,Control,Heart_Failure,non-failing,ischemic or dilating cardiomyopathy,Heart Failure,"non failure vs ischemic and dilating, deselected for now, bowtie throws errors like haymakers. Perhaps this bug can be fixed, so that we can include non illumina systems",,,,,,,,,,0.0,0.0,PRJNA239241,SRP038887,,,JF,
GSE57344,JF,0.0,0.0,0.0,,too few samples,,Illumina Genome Analyzer,PAIRED,0.0,,Control,Heart_Failure,non-failing,ischemic or dilating cardiomyopathy,Heart Failure,Only 6 samples,,,,,,,,,,0.0,0.0,PRJNA246308,SRP041706,,,JF,
GSE61491,JF,0.0,0.0,0.0,,iPSC,,Illumina HiSeq 2000,PAIRED,0.0,human NPCs,Control,CHD8,"For controls, NPCs were treated with shRNAs targeting GFP and LacZ",NPCs treated with shRNAs targeting CHD8,"Memory Disorders|Mental Retardation, X-Linked|Intellectual Disability","batch 2, CDH8 and Controls (GFP); Related disease=Autism but absent from GS2D (Genie(Autism)=>GS2D)",False,,"batch 2, CDH8 and Controls (GFP); Related disease=Autism but absent from GS2D (Genie(Autism)=>GS2D)",CDH8 and Controls (GFP); Related disease=Autism but absent from GS2D (Genie(Autism)=>GS2D),,Proc Natl Acad Sci,25294932.0,11.205,12.291,1.0,1.0,PRJNA261297,SRP047233,,,JF,
GSE63511,JF,0.0,0.0,0.0,,small RNA-seq protocol (miRNA),,Illumina Genome Analyzer IIx,SINGLE,0.0,Thyroid tissue,Normal,Tumour,Papillary Thyroid Carcinoma,Papillary Thyroid Carcinoma,Thyroid Neoplasms,,,,,,,Cancer Res,26282166.0,12.701,12.843,0.0,0.0,PRJNA268095,SRP050087,,,JF,
GSE63744,JF,0.0,0.0,0.0,,weird distribution of gene expression,,Illumina HiSeq 1500,SINGLE,0.0,,healthy,asthma,healthy,asthma,Asthma,Weird distribution of genesâ€™s FDR vs quality,,,,,,,,,,0.0,0.0,PRJNA268971,SRP050390,,,JF,
GSE66207,JF,0.0,0.0,0.0,1.0,,Illumina TruSeq polyA+ Sample Prep Kit,Illumina HiSeq 2500,PAIRED,0.0,Colon,Control,Crohn,Normal (from cancer/disease patient),Crohn's Disease/ B3 penetrating subclass,Crohn Disease,females; RIN available in suppl. Digital content 9 (supp table 7); different disease subgroups have different differential genes,True,,all 6 females B3 diseases (avg 42 years old) + 6 randomly chosen controls (avg 55 years old); Control vs B3 group,,there are also 12 males (6 controls and 6 B1 and B2 diseases) but the disease group is substantially younger,Inflamm Bowel Dis,26164662.0,5.325,3.725,1.0,0.0,PRJNA276116,SRP055438,,,JF,
GSE71613,JF,0.0,0.0,0.0,,few samples; paywall from outside uni,,Illumina HiSeq 2000,PAIRED,0.0,heart,Control,Heart_Failure,non-failing,ischemic or dilating cardiomyopathy,Heart Failure,Only 8 samples,False,NI,no detailed information on samples (may be in publication),,,Cardiol J,28497843.0,2.737,,0.0,0.0,PRJNA291619,SRP061888,,,JF,
GSE73189,JF,1.0,0.0,0.0,1.0,,,Illumina HiSeq 2000,SINGLE,0.0,Lung tissue,Normal,IPF,nomral lung tissue adjacent to benign pulmonary tumors,idiopathic pulmonary fibrosis,Idiopathic Pulmonary Fibrosis,males; last known impact factor from 2016,True,,all control vs IPF males. Similar age per groups (56 vs 58). Chinese study (probably all asian patients),,No extension but article show homogeneity between males and female and also make a single disease group out of 2 subgroups (IPF and INSIP),Oncotarget,29113323.0,5.168,,1.0,0.0,PRJNA296108,SRP063838,,,JF,
GSE74697,JF,1.0,0.0,0.0,1.0,"no demographics data in GEO Series file and SRA, or in article",,Illumina HiSeq 2500,PAIRED,0.0,skin,Control,Psoriasis,healthy skin control,pre-treatment Psoriasis,Psoriasis,study show results only for lncRNAs,False,NI,all 16 controls and 16/18 randomly chosen disease samples. No detailed metadata,,,J Invest Dermatol,27015450.0,8.551,4.368,1.0,0.0,PRJNA301173,SRP065812,,,JF,
GSE76220,JF,1.0,0.0,0.0,1.0,,RNeasy Micro kit (Qiagen),Illumina Genome Analyzer II,SINGLE,0.0,Human Lumbar spinal cord motor neurons,Control,sALS,Control,sALS,Amyotrophic Lateral Sclerosis,"RIN in Table 1 (also table 3?) in paper. Some batch/bias correction in paper ""To obtain a dataset with fewer confounding factors, 1000 genes with the highest PC1-eigenvalues were subtracted from the original dataset.""",True,,"all controls (3/8 females, avg 74 years old) + 8 disease samples (3/8 females, avg 7o years old). Disease samples were selected to match controls as much as possible.",,extended to female (no clear diff in paper),Acta Neuropathol,29881994.0,17.088,20.906,1.0,0.0,PRJNA306659,SRP067645,,,JF,
GSE84445,JF,0.0,0.0,0.0,,unclear results in the paper,,Illumina HiSeq 2500,SINGLE,0.0,,Healthy,Tuberculosis,Healthy,Latent tuberculosis infection,Tuberculosis,Memory CD3+CD4+ T cells,,,,,,,,,,0.0,0.0,PRJNA329186,SRP078560,few deg,,JF,
GSE85567,JF,1.0,0.0,0.0,1.0,,TruSeq RNA Sample Preparation v2 according to the manufacturerï¿½s instructions (Illumina),Illumina HiSeq 2000,SINGLE,0.0,Airway Epithelial cells,Control,Asthma,Control,Asthma,Asthma,"no detailed demographics data in GEO Series file and SRA, or in article. Summary in Table 1. Authors remove unwanted sources of variation using RUVseq: One RUV was significantly correlated with RIN score (P = 1.1 ï¿½ 10ï¿½6), and one was significantly correlated with ethnicity (P = 8.1 ï¿½ 10ï¿½8), average base pair read length (P = 1.4 ï¿½ 10ï¿½7), and flow cell (P = 1.6 ï¿½ 10ï¿½12)",True,,"28 samples in each group (all 28 controls and a random selection of 28/57 diseases); no info at sample's level. From paper: balanced gender and age between the 2 groups (37-39 years, 70-67% female). Same proportions in ethnicity in each group (af am, eu am, other)",,No extension but not all samples were selected (56/85 selected),JCI Insight,27942592.0,8.315,,1.0,0.0,PRJNA338808,SRP081599,,,JF,
GSE92724,JF,0.0,0.0,0.0,,not enough samples; disease group with n=4 (2 males and 2 females); control group n=6 (only females),,Illumina HiSeq 4000,SINGLE,0.0,,Control,Diabetic,Healthy control,Diabetic Patient,"Diabetes Mellitus, Type 2",female only,,,,,,,,,,0.0,0.0,PRJNA358470,SRP095512,,,JF,
GSE99816,JF,0.0,0.0,0.0,,cell lines. only 4 controls when considering duplicates (several samples from same patient),,NextSeq 500,SINGLE,0.0,ileal fibroblast,Control,Crohn,Non Crohn's disease,Crohn's disease,Crohn Disease,Controls vs Non-inflammed Crohn disease; male and female; 2 patients provided each 2 samples; Average age similar (31 vs 36),False,,4 controls (1/4 female) (excliding replicates from same patient) and 4 gender-matching disease samples (Non-inflammed Crohn disease); Average age different 53 vs 36.,,,PLoS ONE,30589872.0,3.24,3.272,1.0,0.0,PRJNA389715,SRP108847,few deg,,JF,
GSE101432,JF,1.0,0.0,0.0,1.0,,see in article,Illumina HiSeq 2000,PAIRED,0.0,liver,Normal,Tumor,Benign adjacent liver sample,primary HCC sample,"Carcinoma, Hepatocellular",Article behind paywall outside uni,True,,"all 15 ""Primary Hepatocellular Carcinoma sample"" male samples and same number of control male samples, only primary tumors. Same avg age for the 2 groups (50 years old)",,,Hepatology,30014619.0,17.425,,1.0,0.0,PRJNA394206,SRP111914,,,MSp,
GSE109203,JF,0.0,0.0,0.0,,only 3 vs 4 samples. No gender or age info,,Illumina HiSeq 2000,PAIRED,0.0,Colorectal tissue,Normal,Tumor,Normal tissue,colorectal tumor,Colorectal Neoplasms,,False,,normal vs well differentiated tumours,,"no, keeping the 2 other groups (they cluster together anyway) would imbalance the comparison to the few normal samples.",Comput Struct Biotechnol J,33304451.0,7.271,,1.0,0.0,PRJNA430130,SRP130989,,,MSp,
GSE111009,JF,0.0,0.0,0.0,,Study not about disease vs control (but silencing),,NextSeq 500,SINGLE,0.0,breast tissue,DMSO,Nutlin3A,Breast Mammary gland,treated with Nutlin3A 5uM,,,True,NI,"most likely all female as only mammary gland samples selected, no age given",,,J Biol Chem,31113863.0,5.157,,1.0,0.0,PRJNA435584,SRP133299,,,MSp,
GSE111523,JF,0.0,0.0,0.0,,Not Illumina. Not really disease study but healing study. Samples pairing mentioned but annotated in GEO and not in SRA metadata. CAN NOT READ ARTICLE FOR MORE INFO => TRY LATER,,Ion Torrent Proton,SINGLE,1.0,palatal gingival tissue,Control,Prewound,normal tissue,human gingival tissue sample,Gingvitis,Unclear pairing information although very likely to be coded in sample names in GEO Series file.,True,NI,"9 each group, no info on sex or age",,,J Clin Periodontol,28005267.0,8.728,5.213,1.0,0.0,PRJNA437298,SRP134099,,,MSp,
GSE113255,JF,0.0,0.0,0.0,,"Only 10 controls without gender info (SRA, paper, supplements) VS 130 other samples with gender info",,NextSeq 500,PAIRED,0.0,mucosa,normal,intestinal,Normal mucosa,intestinal gastric cancer,Stomach Neoplasms|Gastric Neoplasms,,False,,"choose most abbundant tumor type to compare with normal tissue, BUT NORMAL TISSUE IS LESS ABUNDANT OVERALL",,,Gastric Cancer,31773340.0,7.37,7.664,1.0,0.0,PRJNA450596,SRP140636,,,MSp,
GSE113288,JF,0.0,0.0,0.0,,Study not about disease vs control (but silencing),,Illumina Genome Analyzer II,SINGLE,0.0,Human Breast Cancer PDXs,Control,Treat,Cells were infected with pRSI-U6-shLuc-UbiC-TagRFP-2A-Puro vector and selectioned with 3ï¿½g/ml of Puromycin,Cells were infected with pRSI-U6-shWDR5-UbiC-TagRFP-2A-Puro vector and selectioned with 3ï¿½g/ml of Puromycin,Breast Neoplasms,,True,NI,"primary xenographts, but no info on original patient",,,Cancer Res,31752957.0,12.701,12.843,1.0,0.0,PRJNA450653,SRP140715,,,MSp,
GSE117970,JF,1.0,0.0,1.0,1.0,age not given for samples in the selected batch 6,RNAeasy Microkit (Qiagen) according to manufacturerâ€™s instructions,Illumina HiSeq 2500,PAIRED,0.0,monocytes,Normal,Breast_cancer,Normal,Breast cancer,Breast Neoplasms,,True,,Only monocytes; Normal vs Breast cancer (DCIS and invasive breast cancer) in Batch 6. Any age (age not available for all samples). All 11 disease samples and same number of randomly chosen controls,Only monocytes (no tumour associated macrophages); Normal vs invasive breast cancer from batch 1-5,,Cancer Cell,30930117.0,31.743,35.455,1.0,1.0,PRJNA483877,SRP155941,,,MSp,
GSE119234,JF,0.0,0.0,0.0,,too smal and no patient information,,NextSeq 550,PAIRED,0.0,white blood cells,HD,HIV,"healthy donor, white blood cells from lymph nodes","HIV donor, white blood cells from lymph nodes",HIV,white blood cells from lymph node,True,NI,"4 vs 5, no patient metadata",,,Sci Transl Med,31776286.0,17.956,21.12,1.0,0.0,PRJNA488556,SRP159143,,,MSp,
GSE120647,JF,0.0,0.0,0.0,,Study not about disease vs control (but silencing),,Illumina HiSeq 2500,SINGLE,0.0,GCM cell line,control,treated,GBM cells treated with scrambled siRNA,GBM cells treated with Hes3 siRNA,Glioma|Glioblastoma,,True,,Only took one cell line (IDs given),,,FASEB J,31145643.0,5.191,,1.0,0.0,PRJNA493831,SRP162877,,,MSp,
GSE123291,JF,0.0,0.0,0.0,,Study not about disease vs control (but silencing),,Illumina HiSeq 2000,SINGLE,0.0,ABC DLBCL cell line,Control,shEGR1,control shRNA,shRNA treatment,Diffuse large B cell lymphoma,only one cell type selected,True,,"9 samples, 3 controls, same cell line",,add other cell lines (base semms the same,Mol Cancer Res,33980611.0,5.852,6.107,1.0,0.0,PRJNA508194,SRP172098,,,MSp,
GSE127559,JF,0.0,0.0,0.0,,"Incomplete annotation (type, gender and tumor stage) compared to mentions in article",,Illumina HiSeq 2500,PAIRED,0.0,lung tissue,Normal,Tumor,Lung tissue,lung tumor tissue,Lung Neoplasms,,False,,"Different dkk1 level, level info not given for all, no info on patient metadata",,,Cancers (Basel),32224864.0,6.639,6.999,1.0,0.0,PRJNA524920,SRP187151,,,MSp,
GSE133039,JF,1.0,0.0,0.0,1.0,"RIN>7. no detailed demographics data (GEO Series file, SRA, paper)",poly-A enriched RNA of high quality (RIN > 7),Illumina HiSeq 2500,PAIRED,1.0,liver,Nontumor,Tumor,Normal liver tissue,Tumor liver tissue,Liver Neoplasms|Hepatoblastoma,Clear pairing information.,True,,19 pairs of samples (tumour vs control). Only males (more unique samples than for females). Paired design of normal and tumor tissue of the same patients. Two samples per patient (1 normal and 1 tumor with same patient ID),,could expand with females,J Hepatol,32240714.0,25.083,20.888,1.0,0.0,PRJNA549741,SRP201920,,,MSp,
GSE135036,JF,1.0,0.0,0.0,1.0,RIN values in SRA file! Clinical data in Additional File 2.,rRNA depletion. KAPA RNA HyperPrep Kit with RiboseErase (v1.16) (Kapa Biosystems),NextSeq 500,PAIRED,0.0,brain,Control,Matched,Control brain tissue prefrontal cortex,"Tissue of brain with Parkinsons disease, hemisphere matched to symptom predominance",Parkinson Disease,,True,,19 control males and 19 disease males: control and brain (prefrontal cortex) matched to symptoms side. All controls selected in this category except one marked as replicate in additional file 2. disease males were randomly selected among more. Similar average age by group (74),,,Genome Biol,32151270.0,13.583,17.433,1.0,0.0,PRJNA557205,SRP216705,,,MSp,
GSE136630,JF,1.0,0.0,0.0,1.0,Exome Sequencing (Truseq RNA-Access) and few samples but paired,Exome,Illumina HiSeq 2000,PAIRED,1.0,colon tissue,Normal,Tumor,Adjacent normal,colorectal tumor,Colorectal Neoplasms,demographics info in suppl table s1. Clear pairing information.,False,NI,3 females and 2 males.,,,Gut,34059508.0,23.059,22.223,1.0,0.0,PRJNA562898,SRP219837,,,MSp,
GSE141142,JF,0.0,0.0,0.0,,"ethnicity: same for all disease samples (non-hispanic) but not mentioned for all control samples (NA). Checked in article (main text and suppl materials), GEO (Series, SOFT files), SRA metadata.",,NextSeq 500,PAIRED,0.0,breast tissue,Normal,BRCA,Normal tissue,Breast cancer,Breast Neoplasms,,True,,"60 randomly sampled files all female, all white ethnicity, no indication of age, but likely all adults",,more samples available,BMC Cancer,32164626.0,4.43,4.472,1.0,0.0,PRJNA592199,SRP233583,,,MSp,
GSE142334,JF,0.0,0.0,0.0,,no control group. Only follicular lymphoma vs transformed lymphoma,,Illumina HiSeq 2500,PAIRED,0.0,primary lymphoma cells,Follicular,Transformed,Follicular Lymphoma,Transformed follicular lymphoma,"Lymphoma, Follicular",,True,NI,"No info, but paired design",,,Nat Cancer,33569544.0,,,1.0,0.0,PRJNA596663,SRP238213,,,MSp,
GSE144208,JF,0.0,0.0,0.0,,"all cells are iPSC cells derived from few individuals, incl control cells",,Illumina HiSeq 4000,PAIRED,0.0,sensory neurons,healthy,HSN1,Differentiated sensory neurons of healthy control,Differentiated sensory neurons of patients with heredetary sensory neuropathy type 1,Hereditary Sensory and Autonomic Neuropathies,,True,NI,cell lines were at one point derived from a patient but it seems not to be primary cell culture,,,Cell Rep Med,34337561.0,,,1.0,0.0,PRJNA603068,SRP244622,,,MSp,
GSE144269,JF,1.0,0.0,0.0,1.0,"non-tumor and tumor was processed in two batches, but according to paper housekeeping genes are equally expressed. As samples are paired, it is fine for some anayzes, and not for other analyzes",,Illumina NovaSeq 6000,SINGLE,1.0,liver,non-tumor,tumor,liver tissue adjacent,"Liver tissues\, Cancer","Carcinoma, Hepatocellular",Clear pairing information.,False,,"60 randomly samples files of 140. tumor and adjacent tissue of patients is paired, set is balanced",,,Nat Commun,32873799.0,14.919,15.805,1.0,0.0,PRJNA603277,SRP245346,,,MSp,
GSE144736,JF,0.0,0.0,0.0,,iPSC,,NextSeq 500,PAIRED,0.0,iPSC-derived patient neuroepithelium,Control,deletion,control,16p11.2 deletion,Microcephaly,,True,,"negative of Batch 1, 8 male, 11 female","POS, NEG,. male and female mixed",,Elife,33169669.0,8.14,,1.0,1.0,PRJNA604752,,,,MSp,
GSE145645,JF,0.0,0.0,0.0,,"only 3 controls  (3 males; 2 asians) out of 35 samples (males, females, asian, caucasian). No gender or age in SRA metadata. Table S1 contains gender, age and more metadata but impossible to map to SRA ids. => CHECK GEO Series or Soft files for potential ID mapping.",,Illumina HiSeq 2000,PAIRED,0.0,"brain, glia",Normal,Glioblastoma,Normal brain tissue,glioblastoma multiforme,Glioma|Glioblastoma,,True,NI,"Selected only Classical GBM, no proneural or mesenchymal, no info on sex or age",,"could add other samples, clustering is relatively good",Sci Adv,33931443.0,14.136,16.446,1.0,0.0,PRJNA607792,SRP250171,,,MSp,
GSE146944,JF,0.0,0.0,0.0,,"Under embargo in GEO (2022-08-23). too low number of samples, no publication available",,Illumina HiSeq 2500,SINGLE,0.0,PANC1 cells,Non-silencing,HOXC6,pancreatic adenocarcinoma with non-silencing shRNA,PADC with HOXC6 shRNA,"Adenocarcinoma|Adenocarcinoma, pancreatic",the experiment has two different shRNA that target HOX. Only A12 is selected,True,,only 9 samples of which 6 are selected,,,,,,,0.0,0.0,PRJNA612479,SRP252760,,,MSp,
GSE147352,JF,1.0,0.0,0.0,1.0,"15 normal tissue wihtout age & gender info, contrary to the disease samples (article, SRA, GEO Series file)",,Illumina HiSeq 4000,PAIRED,0.0,brain,Normal,gbm,Normal tissue brain,glioblastoma multiforme,Glioma|Glioblastoma,deselected lower grad gliomas,False,,"all 15 controls and 15 gbm without mutation (8 males from 52 to 69, and 8 females from 53 to 68). One GBM sample is left out.",,,Mol Cell,33539787.0,17.97,19.639,1.0,0.0,PRJNA613939,SRP253645,,,MSp,
GSE147761,JF,0.0,0.0,0.0,,exosomal non-coding RNAs biomarkers. No control group,,HiSeq X Ten,PAIRED,0.0,Liquid biopsy (urine),benign,cancer,benign prostatic hyperplasia,prostate cancer,Prostatic Neoplasms,,True,,"all adult men, since its prostate cancer",,,Mol Cancer,34301266.0,27.401,20.26,1.0,0.0,PRJNA616324,SRP254646,,,MSp,
GSE148010,JF,0.0,0.0,0.0,,Study not about disease vs control (but treatment in time series),,Illumina NovaSeq 6000,PAIRED,0.0,TF1 erythroleukemia cell line,pre-treatment,72,pre-treatment,72 hours after treatment,Leucemia,,True,,"Clone IDs equally distributed, but many more samples of other groups",batch 2 is smaller and contains not all types of samples,,Cancer Res,33172974.0,12.701,12.843,1.0,1.0,PRJNA622810,SRP255065,,,MSp,
GSE148036,JF,1.0,0.0,0.0,1.0,few samples: 5 vs 5. all different stages IIB most prevalent.  RNA Integrity Number (RIN) above 7.0.,rRNA depletion. Ribo-Zero rRNA Removal Kits (Illumina),Illumina HiSeq 3000,PAIRED,0.0,lung,Normal,Tumor,normal lung tissue,lung adenocarcinoma,Lung Neoplasms,,True,,3/5 male in control 3/5 female in treat,,,Commun Biol,33097805.0,6.268,6.268,1.0,0.0,PRJNA609278,SRP251945,,,MSp,
GSE151243,JF,1.0,0.0,0.0,1.0,,TO CHECK,Illumina HiSeq 3000,PAIRED,1.0,skin,Perilesion,Lesion,matching perilesion tissue,lesion tissue of hidradenitis suppurativa disease,Hidradenitis Suppurativa,Clear pairing information.,True,,"15 females (30 paired samples), but paired design. Ethnicity W or B (excluding W_A and O)",,there are also 3 males (6 samples),,,,,1.0,0.0,PRJNA635280,SRP264895,,,MSp,
GSE151282,JF,1.0,0.0,0.0,1.0,few samples 4 vs 4,rRNA depletion,Illumina HiSeq 2500,PAIRED,0.0,blood (buffy coat),Healthy,Down-syndrome,healthy blood,blood of trisomy 21 patient,Down Syndrome,,True,,8 samples equally distrtibuted sex and not statistical difference in mean age,,,Hum Genomics,33933170.0,4.639,4.86,1.0,0.0,PRJNA635385,SRP264957,,,MSp,
GSE152683,JF,0.0,0.0,0.0,,infectious disease (vaccination). Likely to be immune-system specific signature instead of disease-specific?,,ILLUMINA,SINGLE,0.0,PBMC,aP,wP,acellular vaccines against Bordetella pertussis,wholeCell vaccines,Whooping Cough|Infections|Respiratory Tract Infections,PBMCs,True,NI,"day 7 was only taken into account, no info on patient demographics again",,,JCI Insight,33690224.0,8.315,,1.0,0.0,PRJNA640099,SRP267676,,,MSp,
GSE153380,JF,0.0,0.0,0.0,1.0,the few PC samples (n=5) are distributed on 2 sequencing batches (GEO Series file).,,Illumina HiSeq 4000,PAIRED,0.0,Plasma Cell,PC,MM,Plasma cell,plasma cell of multiple myeloma,Muliple Myeloma,"subset of MM selected, since there are much more, 4th batch is entierly different cells, omitted",False,NI,"removed samples that had other subtypes as HD (hyperdiploid), no info on patient sex or age",removed samples that had other subtypes as HD (hyperdiploid),,Nat Commun,34521827.0,14.919,15.805,1.0,1.0,PRJNA642175,SRP268939,,,MSp,
GSE154041,JF,0.0,0.0,0.0,,"no control group. Only treatment 1 vs 2. Batch id in sample name (133, 138, ...)?",polyA RNA,NextSeq 500,SINGLE,0.0,"brain, glia",Regorafenib,Lomustine,Regorafenib,Lomustine,Glioma|Glioblastoma-treated,"no normal tissue deselected for now, but could be added later?",True,NI,"no info on sex or age , 60 randomly selected of 71",,,Neuro Oncol,32661549.0,12.3,7.7,1.0,0.0,PRJNA644919,SRP270958,,,Msp,
GSE155559,JF,0.0,0.0,0.0,,Study not about disease vs control (but treatment). All samples are replicates from the same 1 patient.,,NextSeq 500,PAIRED,0.0,whole blood,DMSO,Tamibarotene,AML control,AML treated,"Leukemia|Leukemia, Myeloid, Acute",,True,NI,"no info on sex or age, but only 8 samples",,,Blood Adv,34543389.0,5.486,,1.0,0.0,PRJNA650298,SRP275577,,,MSp,
GSE155800,JF,1.0,0.0,0.0,1.0,,rRNA depletion,Illumina HiSeq 3000,PAIRED,1.0,stromal cells,Normal,tumor,Normal gastrointestinal stromal,Gastrointestinal stromal tumor,Gastrointestinal stromal tumors,Sample pairing mentioned in paper and GEO Series file but not in SRA. Paper focuses on lncRNA. Clear pairing information.,False,NI,"All normal vs all tumor paired samples. Approx balanced gender (6/10 males). Samples pairing should take care of resistant and non resistant groups, treatment time, tumor size and tumor location.",,,Mol Ther Nucleic Acids,34458010.0,8.886,8.051,1.0,0.0,PRJNA655677,SRP276412,,,MSp,
GSE156003,JF,0.0,0.0,0.0,,"No publication, only 6 samples",,Illumina NovaSeq 6000,PAIRED,0.0,Monocytes,mock,VACV,human monocytes before/without VACV infection,VACV infection in Monocytes,Vaccinia virus,,True,,only 6 samples,,,,,,,0.0,0.0,PRJNA656295,SRP276949,,,MSp,
GSE156657,JF,0.0,0.0,0.0,,only 3 controls.,,ILLUMINA,PAIRED,0.0,retina,Control,RB,control retiina,retinoblastoma,Retinoblastoma,https://doi.org/10.1101/2021.02.17.431607,False,,3 vs 7 samples and the three controls have a higher age by man,,,BioRxiv,,,,1.0,0.0,PRJNA658590,SRP278410,,,MSp,
GSE162427,JF,0.0,0.0,0.0,,no control (normal) group,,NextSeq 500,PAIRED,0.0,primary leucemia cells,untreated,calcitriol-treated,untreated cells,oprimary chronic lymphocytic leukemia (CLL) cells,"Leukemia, Lymphocytic, Chronic, B-Cell|Leukemia",,True,NI,No info at all,,,cancers,33466695.0,6.639,6.999,1.0,0.0,PRJNA681850,SRP295372,,,MSp,
GSE162760,JF,0.0,0.0,0.0,,infectious disease,,NextSeq 500,SINGLE,0.0,PBMC,Control,cutaneous,control blood,Cutaneous leishmaniasis whole blood,"Leishmaniasis, Cutaneous",Used ComBat and used batch as confounding factor for DE,False,,"Only picked batch 1, 6 ctrl 12 cutaneous, was not able to balance for sex",took all data big number of samples,"could include batch 2, very similar to batch 1 plow-wise",PLoS Negl Trop Dis,33793565.0,4.411,,1.0,1.0,PRJNA682985,SRP296765,,,MSp,
GSE163214,JF,0.0,0.0,1.0,,siRNA silencing,,ILLUMINA,SINGLE,0.0,HeLa Kyoto,control,JAZF1-knockdown,Hela KYOTO CELLS,SAME CELLS WITH ko,,,True,,"all samples form cell line female based Hs, cervix carcinoma cell",,"both batches kept for normal analysis, else the set is to small (6 vs 10 samples)",Int J Mol Sci,33445503.0,5.923,6.132,0.0,1.0,PRJNA685204,SRP297944,,,MSp,
GSE163424,JF,0.0,0.0,0.0,,"Mice data. too small only 6 samples, the paper is most likely right, but was not linked and not a direct find.",,Illumina HiSeq 2500,PAIRED,0.0,MM425X,Vehicle,Niraparib,untreated PDX tumor cell,PDX treated with Niraparib,Melanoma,,True,,"only 6 samples, all from PDX cell line",,,J Invest Dermatol,33610559.0,8.551,8.452,0.0,0.0,PRJNA686436,SRP298507,,,MSp,
GSE163857,JF,0.0,0.0,0.0,,iPSC cells,,NextSeq 500,SINGLE,0.0,"brain, IPSC",CTL,Zn,Control?,Treated with Zinc,,No mention of batch in the paper itself,True,,"More female than male, selected equally (2 of each Zn 4 of each CTL)","More female than male, batch 2 is much smaller than batch 3",,iScience,34746703.0,5.458,,1.0,1.0,PRJNA687763,SRP299450,,,MSp,
GSE163908,JF,0.0,0.0,0.0,,too small only 6 samples. Treatment experiment instead of disease,,Illumina NovaSeq 6000,PAIRED,0.0,MRC5 cells,Control,Treated,lung fibroblasts treated with media from ATII cells,lung fibros treated with media of the same cells treated with 4-OHT,Idiopathic Pulmonary Fibrosis,,True,,only 6 samples,,,J Biol Chem,34418430.0,5.157,,0.0,0.0,PRJNA688158,SRP299376,,,MSp,
GSE164158,JF,1.0,0.0,0.0,1.0,Chinese study,NEBNext Ultra Directional RNA Library Prep Kit for Illumina,HiSeq X Ten,PAIRED,1.0,esophageal tissue,Normal,ESCC,Adjacent normal,esophageal squamous cell carcinoma,"Carcinoma, Squamous Cell",Clear pairing information.,True,,"2/8 females per group, different stages, but all cluster together. Samples pairing.",,,Front Genet,33552118.0,3.789,,1.0,0.0,PRJNA689307,SRP300091,,,MSp,
GSE164213,JF,1.0,0.0,0.0,1.0,,polyA RNA,ILLUMINA,PAIRED,0.0,CD4 Cells,Control,active-JIA,Healthy Control,active Juvenile Idiopathic Arthritis om Treatment,"Arthritis, Juvenile","RNeasy MiniElute Cleanup kit. Purification of total RNA, miRNA, poly A+ mRNA, DNA or protein",True,NI,All 10 controls and 10/12 randomly selectd disease samples. No info on demographics in SRA and GEO. From paper: Patients included 18 girls and 4 boys who ranged in age from 4 to 16 years; Healthy control (HC) children (n?=?10) [...] and ranged in age from 5 to 16 years and included two boys and eight girls,,,Sci Rep,33597588.0,4.379,5.133,1.0,0.0,PRJNA689564,SRP300217,,,MSp,
GSE165286,JF,0.0,0.0,0.0,1.0,few samples without demographics,"Trizol (Ambion, Thermo Fisher, USA)",Illumina HiSeq 4000,PAIRED,0.0,"brain, glia",Normal,GBM,Normal brain tissue,glioblastoma multiforme,Glioma|Glioblastoma,,False,NI,"4/8 gbm (random selection) and 4 normal samples; no info on sex or age (GEO, SRA or paper)",,,Sci Rep,33911148.0,4.379,5.133,1.0,0.0,PRJNA693873,SRP302777,,,MSp,
GSE165595,JF,1.0,0.0,0.0,1.0,,Illumina TruSeq Stranded Total RNA LT Sample Prep Kit,Illumina HiSeq 4000,PAIRED,1.0,brain,Normal,Tumor,Normal (from cancer/disease patient),oligodendroglioma,Glioma|Oligodendroglioma,"demographics data in pdf in suppl table 1. For GBM, there are 11 males + 4 females but paired samples (normal vs disease). Clear pairing information.",True,NI,"11 paired set of gbm and Normal of the same case, only males (38-73)",,,Commun Biol,35042936.0,6.268,6.268,1.0,0.0,PRJNA695017,SRP303386,,,MSp,
GSE165870,JF,0.0,0.0,0.0,,only 3 control samples (unbalanced as 2/3 females) vs balanced disease group (6 samples),,Illumina NovaSeq 6000,PAIRED,0.0,Bone Marrow,Ctrl,non-SAA,Healthy donor,Aplastic Anemia,"Anemia, Aplastic",,False,,male female is balanced but Ctrl vs treat is not (3 v 6),,,Blood,33763704.0,23.629,,1.0,0.0,PRJNA698389,SRP304033,,,MSp,
GSE166638,JF,0.0,0.0,0.0,,scRNAseq,,NextSeq 500,PAIRED,0.0,CD4 Cells,blood,hematoma,PBMCs,blood cells from hematoma drainage,Cerebral Hemorrhage,"sc Data available but not in metafile (see sra), deselected, does not work with rasflow, strange error during quantify",True,,"As Donor there is only PT, so it could be that it is always the same person and oinly different replicates of heamorage or normal blood",,,JCI Insight,33749664.0,8.315,,0.0,0.0,PRJNA701458,SRP305908,,,MSp,
GSE171343,JF,0.0,0.0,0.0,,iPSC time series,,Illumina HiSeq 4000,PAIRED,0.0,iPSC derived cerebral organoid,2mo,6mo,GIH-6-C1-{delta}A02 after 2 months,GIH-6-C1-{delta}A02 after 4 months,Dementia,"Subset selected, there are other ages (6mo) and multiple cell lines used",True,,"organoids, all from the same cell line. only samples from 2mo and 6 mo picked, as opposed to 2 and 4 of before.","organoids, all from the same cell line. only also 4mo samples picked",,Cell,34314701.0,41.582,46.898,1.0,1.0,PRJNA719235,SRP313301,,,MSp,
GSE171643,JF,0.0,0.0,0.0,,only 4 patients and 4 controls without demographics,"RNeasy Plus minikit (Qiagen, Germantown, MD)",Illumina HiSeq 4000,SINGLE,0.0,muscle tissue,Control,Cirrhosis,Vastus lateralis_without cirrhosis,Vastus lateralis_with cirrhosis,Fibrosis|Muscle Cirrhosis,,False,NI,"only 8 samples, but no info on sex or age (GEO, SRA and paper)",,,J Biol Chem,34343564.0,5.157,,1.0,0.0,PRJNA720402,SRP313828,,,MSp,
GSE173078,JF,1.0,0.0,1.0,1.0,only 4 patients and 4 controls,paper behind paywall,Illumina HiSeq 4000,SINGLE,0.0,Gingival tissue,Normal,gingivitis,Normal gingival tissue,ginival tissue from periodontitis,Gingivitis,also contains deselected periodontitis,False,,"From batch A (0), only female, healthy and gingivitis groups, diverse but balanced age and ethnicity","2 batches; all samples selected, containing 3 groups",,J Clin Periodontol,34101221.0,8.728,,1.0,1.0,PRJNA723754,SRP315849,,,MSp,
GSE174330,JF,1.0,0.0,0.0,1.0,"unbalanced for gender (35/52 females in european americans); no info on age, probable batches and samples pairing (the latter being unclear at best). Mixing tumor sub-types and stages (no detailed info, only summary in Table 1). The following have been checked: GEO Series file, SRA and paper incl. supplements.","RNA was harvested using Tryzol reagent. QuantSeq Rev 3â€™mRNA-Seq Library Prep Kit for Illumina (Lexogen, Vienna, Austria)",Illumina HiSeq 2500,SINGLE,0.0,lung,Normal,Tumor,normal lung tissue,non-small cell lung cancer,Lung Neoplasms,"No info on age, sex and pairing, except summary in Table 1 (10/46 african american males; 17/52 european american males). Samples pairing may be in GEO Series files as sample name but using it leads to partially inconsistant ethny/race for some pairs. No info on batches, except: ""Libraries were pooled and sequenced on the Illumina Hiseq 2500 with 100 bp single end reads"" and ""Eight samples were run per lane, including 4 tumors and 4 adjacent non-involved samples derived from 2 AA and 2 EA to limit bias"".",False,NI,"50/100 european american samples (25 controls and 25 disases) even if no pairing info, unbalanced gender (35/52 females), tumor sub-types (Adenocarcinoma, Squamous, other) and stages (1, 2, 3), and no info on age and batches.",,more are available,Nat Commun,34556645.0,14.919,15.805,1.0,0.0,PRJNA729468,SRP319473,,,MSp,
GSE179397,JF,1.0,0.0,0.0,1.0,only 4 patients and 4 controls,"TruSeqâ„¢ RNA Sample Preparation Kit (Illumina, USA) following the TruSeqâ„¢ RNA sample preparation guide. Briefly, the poly-A containing mRNA molecules were purified",Illumina NovaSeq 6000,PAIRED,0.0,pericardial adipose tissue,Control,CAD,Pericardial Adipose tissue control patients,Pericardial Adipose tissue cad patients,Coronary Artery Disease|Coronary Disease,,False,NI,"all 4 control (3/4 males) and 4/5 randomly selected males CAD. GEO, SRA: no dempgraphics info but summary in suppl table 1. Biased by more hypertensed in CAD group",,,Front Endocrinol (Lausanne),34552562.0,5.555,,1.0,0.0,PRJNA743540,SRP326808,,,MSp,
GSE179448,JF,1.0,0.0,0.0,1.0,,,NextSeq 500,PAIRED,0.0,T Cell,Healthy,outpatient,Tconv cells of healthy donors,tTconv cells of Covid19 patients,Coronavirus,"Subset taken, there is another cell type (Treg) and multiple other severities (hospitalized, Recovered). There are 2 RNA-seq batches and 11 sample-processing batches (different dates of extraction and preparation). Demographics and clinical info in paper's supplemental dataset S01. Multiple facotrs that overlap with batch (two technical batches, different ages, different sexes)",False,,"Tconv; RNA-seq batch 1; 6 healthy (23-32 years old, 4/6 females); 6 outpatients (23-31 years old, 4/6 females)",,"could reduce data dramatically, but patient ID is linkable with GSM",Proc Natl Acad Sci USA,34433692.0,11.205,10.285,0.0,0.0,PRJNA743862,SRP326974,,,MSp,
GSE179882,JF,0.0,0.0,0.0,,interference study; transduced controls; are astrocytes appropriate controls for GBM?,,Illumina HiSeq 2500,PAIRED,0.0,Astrocytes|GBM,Normal,GBM,Normal human astrocytes,GBM,Glioma|Glioblastoma,"only subset can be used, too many groups, only control groups used, knockouts discarded",True,,selected only control and non changed brain tumor cells,,,JCI Insight,34494550.0,8.315,,1.0,0.0,PRJNA745459,SRP327853,,,MSp,
GSE180415,JF,0.0,0.0,0.0,,"Severe gender and age imbalance between groups. no demographics info in SRA or GEO Series file, but in suppl table 1.",Trizol and the Qiagen RNeasy kit (Qiagen),Illumina HiSeq 4000,PAIRED,0.0,lung fibroblasts,normal,diseased,fibroblast of healthy individuual,fibroblasts of IPF,Idiopathic Pulmonary Fibrosis,,True,NI,"No info on sex or age, 9 samples",,,Am J Respir Cell Mol Biol,34370624.0,6.914,,1.0,0.0,PRJNA748086,SRP328996,,,MSp,
GSE180882,JF,0.0,0.0,0.0,,many samples but replicates from same few donors. In vitro differentiation study,,Illumina NovaSeq 6000,SINGLE,0.0,liver,Healthy,NASH,healthy liver explant,NASH liver explant,Non-alcoholic Fatty Liver Disease,"only subset can be used, too many groups",True,,"healthy samples are more unbalanced towards female, but enough male samples, picked only living healthy donors, tried to minimize redundancy of diseased donor samples picked 2 each",,could add dead donors,Hepatology,33901295.0,17.425,,1.0,0.0,PRJNA749873,SRP329969,,,MSp,
GSE181376,JF,0.0,0.0,0.0,,can not read paper (paywall). Few samples without treatment: 4 vs 4,,NextSeq 500,SINGLE,0.0,myoblasts,TD,CP,typically developing,cerebral plasy,Cerebral plasy,Experiment has patients vs normaative control and treatment with AZA. Only non treated are used (8samples a 4),True,,"1 female per group, all children, all untreated ï¿½ treated groups are not included in MEGA table",,,FASEB J,34559924.0,5.191,,1.0,0.0,PRJNA751988,SRP331012,,,MSp,
GSE181458,JF,0.0,0.0,0.0,,"no control group, too few samples (n=8)",,NextSeq 500,PAIRED,0.0,lymph node tissue,GCB,WT_ABC,GCB subtype of DLBCL,ABC subtype of DLBCL,Diffuse large B cell lymphoma,"No normal tissue, only two different subtypes of a disease against each other",True,NI,"only 8 samples, but no info on sex or age",,,,,,,1.0,0.0,PRJNA752102,SRP331115,,,MSp,
GSE182440,JF,1.0,0.0,0.0,1.0,"Cases and controls were matched by race, sex, age, etc.. But, severe imbalance between groups for cause of death (cardiac for controls), brain region (right for disordered), and smoking status (disordered are current smokers)","rRNA depletion. The KAPA RNA HyperPrep Kit with RiboErase (KAPA Biosystems, Wilmington, MA, USA)",ILLUMINA,PAIRED,0.0,Human postmortem putamen,Control,AlcoholUseDisorder,post mortem putamen non alcoholic,post mortem putamen Alcoholic,Alcoholism,"Very well annotated data, RIN present, different brain relevant measurements and sex",True,,6 disordered and 6 controls from batch 1. equally distributed female and male,,,Transl Psychiatry,34601489.0,6.222,7.097,1.0,1.0,PRJNA756274,SRP333341,,,MSp,
GSE201482,JF,0.0,0.0,0.0,,blood samples to check cognitive functions,,Illumina NovaSeq 6000,PAIRED,0.0,whole blood,SCD,VCI,"cardio vacular disease, normal cognitive func","cvd, impaired cognitive function",Cardiovascular Diseases,whole blood,True,NI,"10 of each group, but no info on patients metadata",,,Not yet published,,,,1.0,0.0,PRJNA831858,SRP372171,,,MSp,
GSE45419,JF,0.0,0.0,0.0,,no normal tissue,Polyladenylylated RNA,Illumina Genome Analyzer IIx,PAIRED,0.0,"breast tissue, HMEC (benign cell line)",Control,Tumor,Benign cell lines (HMEC),Breast cancer,Breast Neoplasms,,False,,Two groups of tumors ER+ and triple negative BT,,keep both (the cluster together anyway),PloS One,24223926.0,3.24,3.272,1.0,0.0,PRJNA193673,SRP019936,,,MSp,
GSE50760,JF,0.0,0.0,0.0,1.0,no detailed demographics data but paired,"TruSeq RNA Sample Preparation kit v2 (Illumina, CA, USA) (purified from total RNA using poly-T oligo-attached magnetic beads)",Illumina HiSeq 2000,PAIRED,1.0,colon,normal,primary,normal colon,coloractal cancer,Colorectal Neoplasms,no detailed demographics but summary in suppl data (15/18 male donors). Pairing derived from sample names in GEO Series (not explicitly given). Unclear pairing information.,True,NI,all 36 paired primary-tumor samples (18 patients),,,Mol Oncol,25049118.0,7.449,,1.0,0.0,PRJNA218851,SRP029880,,,MSp,
GSE51005,JF,0.0,0.0,0.0,,no normal tissue,,Illumina HiSeq 2000,PAIRED,0.0,prostate tissue,Pre-treatment,Post-treatment,Prostate cancer before treatment,Prostate cancer after treatment,Prostatic Neoplasms,,True,NI,"all men by nature of disease, most likely not young individuals, but no info given",,,BMC Cancer,25519703.0,4.43,4.472,1.0,0.0,PRJNA219507,SRP030027,,,MSp,
GSE57253,JF,0.0,0.0,0.0,,no normal tissue but treatment study,,Illumina HiSeq 2000,SINGLE,0.0,NOMID,NOMID-pre,NOMID-post,Neonatal-Onset Multisystem Inflammatory Disease (NOMID) before treat with anakinra,Neonatal-Onset Multisystem Inflammatory Disease (NOMID) after treat with anakinra,Hereditary Autoinflammatory Diseases|    Cryopyrin-Associated Periodic |omes,,True,NI,"no info given, but 8 vs 8 NOMID",,,Nat Genet,25217959.0,38.33,36.431,1.0,0.0,PRJNA246060,SRP041620,,,MSp,
GSE77314,JF,1.0,0.0,0.0,1.0,no detailed demographics data but paired,Trizol reagent (Invitrogen,Illumina Genome Analyzer,PAIRED,1.0,liver,Normal,Tumor,normal liver,HCC,"Carcinoma, Hepatocellular",No info on batch but large. Clear pairing info from GEO Series file. Clinical info in Table S1D (43/50 males),False,NI,"randomly selected 60/100 paired samples (30 pairs), no detailed demographics info  (43/50 males)",,40 more samples available,Oncotarget,27119355.0,3.331,3.707,1.0,0.0,PRJNA310012,SRP068976,,,MSp,
GSE79362,JF,1.0,0.0,0.0,1.0,,,Illumina HiSeq 2000,PAIRED,0.0,PBMC,Control,Case,non progressor,progressor tuberculosis,Tuberculosis,No info on batch (except if column 'bin' means batch) but large,True,,"24 male cases in different bins and 24 controls in same bins (same number per bin as cases) (bin may mean batch), only males, previous diag of tb = n, ethny: coloured (not black)",,"much more samples available, but difference between treat and ctrl is nott strong",Lancet,27017310.0,75.321,77.237,1.0,0.0,PRJNA315611,SRP071965,,,MSp,
GSE81871,JF,0.0,0.0,0.0,,Study not about disease vs control (but silencing). Only a Preprint,,Illumina HiSeq 2500,SINGLE,0.0,T cell,treated,treated-and-rested,pbmcs IL-7 treated,pbmcs IL-7 treated and rested,,"for qcgenes only batch 2 LV sh-TRIM28b are selected, for batch all are selected",True,NI,"all samples cd4+ lymphocytes, only indication of confounding facotr is batch, two sets from batch 2 were chosen for qcgenes analysis",,,BioRxiv,,,,0.0,0.0,PRJNA322833,SRP075692,,,MSp,
GSE82177,JF,1.0,0.0,1.0,1.0,,,Illumina HiSeq 2000,SINGLE,0.0,liver,Non_Tumor,Tumor,Biopsy of HCV+ Non-neoplastic,Biopsy of HCV+ HCC tumor,"Carcinoma, Hepatocellular",Batch 1 (not batch 0); male & female; HCV infected; Some weird distribution of genesï¿½s FDR vs quality,True,,"all 5 tumours and 5 non-tumours in batch 1. less female than male, but equal number of females distributed",only Tumor vs non_tumor,could expand with control group for batch analysis,Oncogene,27721404.0,9.867,8.858,1.0,1.0,PRJNA324260,SRP076032,few deg,,MSp,
GSE105130sub_simi_low_0,,1.0,,,,,,,,0.0,,Adjacent-non-tumour,tumor,,,,,,,,,,,,,,,,,,,,,
GSE105130sub_simi_high_0,,1.0,,,,,,,,0.0,,Adjacent-non-tumour,tumor,,,,,,,,,,,,,,,,,,,,,
GSE105130sub_diff_tu_low_0,,1.0,,,,,,,,0.0,,Adjacent-non-tumour,tumor,,,,,,,,,,,,,,,,,,,,,
GSE105130sub_diff_tu_high_0,,1.0,,,,,,,,0.0,,Adjacent-non-tumour,tumor,,,,,,,,,,,,,,,,,,,,,
GSE105130sub_simi_low_1,,1.0,,,,,,,,0.0,,Adjacent-non-tumour,tumor,,,,,,,,,,,,,,,,,,,,,
GSE105130sub_simi_high_1,,1.0,,,,,,,,0.0,,Adjacent-non-tumour,tumor,,,,,,,,,,,,,,,,,,,,,
GSE105130sub_diff_tu_low_1,,1.0,,,,,,,,0.0,,Adjacent-non-tumour,tumor,,,,,,,,,,,,,,,,,,,,,
GSE105130sub_diff_tu_high_1,,1.0,,,,,,,,0.0,,Adjacent-non-tumour,tumor,,,,,,,,,,,,,,,,,,,,,
GSE105130sub_simi_low_2,,1.0,,,,,,,,0.0,,Adjacent-non-tumour,tumor,,,,,,,,,,,,,,,,,,,,,
GSE105130sub_simi_high_2,,1.0,,,,,,,,0.0,,Adjacent-non-tumour,tumor,,,,,,,,,,,,,,,,,,,,,
GSE105130sub_diff_tu_low_2,,1.0,,,,,,,,0.0,,Adjacent-non-tumour,tumor,,,,,,,,,,,,,,,,,,,,,
GSE105130sub_diff_tu_high_2,,1.0,,,,,,,,0.0,,Adjacent-non-tumour,tumor,,,,,,,,,,,,,,,,,,,,,
GSE144269sub_simi_low_0,,1.0,,,,,,,,0.0,,non-tumor,tumor,,,,,,,,,,,,,,,,,,,,,
GSE144269sub_simi_high_0,,1.0,,,,,,,,0.0,,non-tumor,tumor,,,,,,,,,,,,,,,,,,,,,
GSE144269sub_diff_tu_low_0,,1.0,,,,,,,,0.0,,non-tumor,tumor,,,,,,,,,,,,,,,,,,,,,
GSE144269sub_diff_tu_high_0,,1.0,,,,,,,,0.0,,non-tumor,tumor,,,,,,,,,,,,,,,,,,,,,
GSE144269sub_simi_low_1,,1.0,,,,,,,,0.0,,non-tumor,tumor,,,,,,,,,,,,,,,,,,,,,
GSE144269sub_simi_high_1,,1.0,,,,,,,,0.0,,non-tumor,tumor,,,,,,,,,,,,,,,,,,,,,
GSE144269sub_diff_tu_low_1,,1.0,,,,,,,,0.0,,non-tumor,tumor,,,,,,,,,,,,,,,,,,,,,
GSE144269sub_diff_tu_high_1,,1.0,,,,,,,,0.0,,non-tumor,tumor,,,,,,,,,,,,,,,,,,,,,
GSE144269sub_simi_low_2,,1.0,,,,,,,,0.0,,non-tumor,tumor,,,,,,,,,,,,,,,,,,,,,
GSE144269sub_simi_high_2,,1.0,,,,,,,,0.0,,non-tumor,tumor,,,,,,,,,,,,,,,,,,,,,
GSE144269sub_diff_tu_low_2,,1.0,,,,,,,,0.0,,non-tumor,tumor,,,,,,,,,,,,,,,,,,,,,
GSE144269sub_diff_tu_high_2,,1.0,,,,,,,,0.0,,non-tumor,tumor,,,,,,,,,,,,,,,,,,,,,
GSE133039sub_simi_low_0,,1.0,,,,,,,,0.0,,Nontumor,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE133039sub_simi_high_0,,1.0,,,,,,,,0.0,,Nontumor,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE133039sub_diff_tu_low_0,,1.0,,,,,,,,0.0,,Nontumor,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE133039sub_diff_tu_high_0,,1.0,,,,,,,,0.0,,Nontumor,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE133039sub_simi_low_1,,1.0,,,,,,,,0.0,,Nontumor,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE133039sub_simi_high_1,,1.0,,,,,,,,0.0,,Nontumor,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE133039sub_diff_tu_low_1,,1.0,,,,,,,,0.0,,Nontumor,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE133039sub_diff_tu_high_1,,1.0,,,,,,,,0.0,,Nontumor,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE133039sub_simi_low_2,,1.0,,,,,,,,0.0,,Nontumor,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE133039sub_simi_high_2,,1.0,,,,,,,,0.0,,Nontumor,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE133039sub_diff_tu_low_2,,1.0,,,,,,,,0.0,,Nontumor,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE133039sub_diff_tu_high_2,,1.0,,,,,,,,0.0,,Nontumor,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE114564sub_simi_low_0,,1.0,,,,,,,,0.0,,Normal,Advanced_HCC,,,,,,,,,,,,,,,,,,,,,
GSE114564sub_simi_high_0,,1.0,,,,,,,,0.0,,Normal,Advanced_HCC,,,,,,,,,,,,,,,,,,,,,
GSE114564sub_diff_tu_low_0,,1.0,,,,,,,,0.0,,Normal,Advanced_HCC,,,,,,,,,,,,,,,,,,,,,
GSE114564sub_diff_tu_high_0,,1.0,,,,,,,,0.0,,Normal,Advanced_HCC,,,,,,,,,,,,,,,,,,,,,
GSE114564sub_simi_low_1,,1.0,,,,,,,,0.0,,Normal,Advanced_HCC,,,,,,,,,,,,,,,,,,,,,
GSE114564sub_simi_high_1,,1.0,,,,,,,,0.0,,Normal,Advanced_HCC,,,,,,,,,,,,,,,,,,,,,
GSE114564sub_diff_tu_low_1,,1.0,,,,,,,,0.0,,Normal,Advanced_HCC,,,,,,,,,,,,,,,,,,,,,
GSE114564sub_diff_tu_high_1,,1.0,,,,,,,,0.0,,Normal,Advanced_HCC,,,,,,,,,,,,,,,,,,,,,
GSE114564sub_simi_low_2,,1.0,,,,,,,,0.0,,Normal,Advanced_HCC,,,,,,,,,,,,,,,,,,,,,
GSE114564sub_simi_high_2,,1.0,,,,,,,,0.0,,Normal,Advanced_HCC,,,,,,,,,,,,,,,,,,,,,
GSE114564sub_diff_tu_low_2,,1.0,,,,,,,,0.0,,Normal,Advanced_HCC,,,,,,,,,,,,,,,,,,,,,
GSE114564sub_diff_tu_high_2,,1.0,,,,,,,,0.0,,Normal,Advanced_HCC,,,,,,,,,,,,,,,,,,,,,
GSE77314sub_simi_low_0,,1.0,,,,,,,,0.0,,Normal,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE77314sub_simi_high_0,,1.0,,,,,,,,0.0,,Normal,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE77314sub_diff_tu_low_0,,1.0,,,,,,,,0.0,,Normal,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE77314sub_diff_tu_high_0,,1.0,,,,,,,,0.0,,Normal,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE77314sub_simi_low_1,,1.0,,,,,,,,0.0,,Normal,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE77314sub_simi_high_1,,1.0,,,,,,,,0.0,,Normal,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE77314sub_diff_tu_low_1,,1.0,,,,,,,,0.0,,Normal,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE77314sub_diff_tu_high_1,,1.0,,,,,,,,0.0,,Normal,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE77314sub_simi_low_2,,1.0,,,,,,,,0.0,,Normal,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE77314sub_simi_high_2,,1.0,,,,,,,,0.0,,Normal,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE77314sub_diff_tu_low_2,,1.0,,,,,,,,0.0,,Normal,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE77314sub_diff_tu_high_2,,1.0,,,,,,,,0.0,,Normal,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE174330sub_simi_low_0,,1.0,,,,,,,,0.0,,Normal,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE174330sub_simi_high_0,,1.0,,,,,,,,0.0,,Normal,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE174330sub_diff_tu_low_0,,1.0,,,,,,,,0.0,,Normal,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE174330sub_diff_tu_high_0,,1.0,,,,,,,,0.0,,Normal,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE174330sub_simi_low_1,,1.0,,,,,,,,0.0,,Normal,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE174330sub_simi_high_1,,1.0,,,,,,,,0.0,,Normal,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE174330sub_diff_tu_low_1,,1.0,,,,,,,,0.0,,Normal,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE174330sub_diff_tu_high_1,,1.0,,,,,,,,0.0,,Normal,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE174330sub_simi_low_2,,1.0,,,,,,,,0.0,,Normal,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE174330sub_simi_high_2,,1.0,,,,,,,,0.0,,Normal,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE174330sub_diff_tu_low_2,,1.0,,,,,,,,0.0,,Normal,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE174330sub_diff_tu_high_2,,1.0,,,,,,,,0.0,,Normal,Tumor,,,,,,,,,,,,,,,,,,,,,
GSE85567sub_simi_low_0,,1.0,,,,,,,,0.0,,Control,Asthma,,,,,,,,,,,,,,,,,,,,,
GSE85567sub_simi_high_0,,1.0,,,,,,,,0.0,,Control,Asthma,,,,,,,,,,,,,,,,,,,,,
GSE85567sub_diff_tu_low_0,,1.0,,,,,,,,0.0,,Control,Asthma,,,,,,,,,,,,,,,,,,,,,
GSE85567sub_diff_tu_high_0,,1.0,,,,,,,,0.0,,Control,Asthma,,,,,,,,,,,,,,,,,,,,,
GSE85567sub_simi_low_1,,1.0,,,,,,,,0.0,,Control,Asthma,,,,,,,,,,,,,,,,,,,,,
GSE85567sub_simi_high_1,,1.0,,,,,,,,0.0,,Control,Asthma,,,,,,,,,,,,,,,,,,,,,
GSE85567sub_diff_tu_low_1,,1.0,,,,,,,,0.0,,Control,Asthma,,,,,,,,,,,,,,,,,,,,,
GSE85567sub_diff_tu_high_1,,1.0,,,,,,,,0.0,,Control,Asthma,,,,,,,,,,,,,,,,,,,,,
GSE85567sub_simi_low_2,,1.0,,,,,,,,0.0,,Control,Asthma,,,,,,,,,,,,,,,,,,,,,
GSE85567sub_simi_high_2,,1.0,,,,,,,,0.0,,Control,Asthma,,,,,,,,,,,,,,,,,,,,,
GSE85567sub_diff_tu_low_2,,1.0,,,,,,,,0.0,,Control,Asthma,,,,,,,,,,,,,,,,,,,,,
GSE85567sub_diff_tu_high_2,,1.0,,,,,,,,0.0,,Control,Asthma,,,,,,,,,,,,,,,,,,,,,
GSE54456sub_simi_low_0,,1.0,,,,,,,,0.0,,normal_skin,Psoriasis_skin,,,,,,,,,,,,,,,,,,,,,
GSE54456sub_simi_high_0,,1.0,,,,,,,,0.0,,normal_skin,Psoriasis_skin,,,,,,,,,,,,,,,,,,,,,
GSE54456sub_diff_tu_low_0,,1.0,,,,,,,,0.0,,normal_skin,Psoriasis_skin,,,,,,,,,,,,,,,,,,,,,
GSE54456sub_diff_tu_high_0,,1.0,,,,,,,,0.0,,normal_skin,Psoriasis_skin,,,,,,,,,,,,,,,,,,,,,
GSE54456sub_simi_low_1,,1.0,,,,,,,,0.0,,normal_skin,Psoriasis_skin,,,,,,,,,,,,,,,,,,,,,
GSE54456sub_simi_high_1,,1.0,,,,,,,,0.0,,normal_skin,Psoriasis_skin,,,,,,,,,,,,,,,,,,,,,
GSE54456sub_diff_tu_low_1,,1.0,,,,,,,,0.0,,normal_skin,Psoriasis_skin,,,,,,,,,,,,,,,,,,,,,
GSE54456sub_diff_tu_high_1,,1.0,,,,,,,,0.0,,normal_skin,Psoriasis_skin,,,,,,,,,,,,,,,,,,,,,
GSE54456sub_simi_low_2,,1.0,,,,,,,,0.0,,normal_skin,Psoriasis_skin,,,,,,,,,,,,,,,,,,,,,
GSE54456sub_simi_high_2,,1.0,,,,,,,,0.0,,normal_skin,Psoriasis_skin,,,,,,,,,,,,,,,,,,,,,
GSE54456sub_diff_tu_low_2,,1.0,,,,,,,,0.0,,normal_skin,Psoriasis_skin,,,,,,,,,,,,,,,,,,,,,
GSE54456sub_diff_tu_high_2,,1.0,,,,,,,,0.0,,normal_skin,Psoriasis_skin,,,,,,,,,,,,,,,,,,,,,
